This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Obesity Alone May Not Affect Knee Replacement Outcome Or Increase Overall Complication Risk

Obese patients undergoing total knee replacement face longer hospital stays, higher related costs

CHICAGO, March 21, 2013 /PRNewswire-USNewswire/ -- Obesity alone may not diminish outcomes or increase the risk of complications in total knee replacement (TKR) patients, according to two research studies presented today at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).  However, TKR replacement patients may face significantly longer hospital stays and related costs.

Total knee replacement in obese patients previously has been associated with increased post-operative complications and lower clinical function scores in multiple research studies.

In the study, " The Effect of Obesity on Direct Medical Costs in Total Knee Arthroplasty (TKA)" researchers reviewed the records of more than 8,000 patients who had undergone single, primary or revision TKR procedures between 2000 and 2008, collecting data on clinical and surgical characteristics, complications and hospital costs. Patients were classified into eight groups based on body mass index (BMI) and comorbidities (diabetes, hypertension, etc.).

Length of hospital stay and direct medical costs were lowest for patients with a BMI of 25-30kg/m 2.  Greater BMI was associated with significantly longer hospital stays after adjusting for age, sex, type of surgery and comorbidities. Every 5 unit increase in BMI beyond 30 kg/m 2 was associated with approximately $250-$300 in higher hospitalization costs for primary knee arthroplasty and $600-$650 higher hospitalization costs for revision procedures.

Although increasing BMI was not associated with an overall increase in complication risk during the 90-day window, there was a higher rate of infection in obese patients.

"The costs associated with obesity are believed to be largely those that come from managing comorbid medical conditions linked to obesity, such as diabetes," said lead study author Hilal Maradit-Kremers, MD, an associate professor of epidemiology at Mayo Clinic in Rochester, Minn.  In this study, "we attempted to tackle this problem by restricting the analysis to patients without comorbid conditions. Even in the absence of comorbidities, obesity was still associated with longer stays and higher hospital costs."

"The bottom line is that obesity is increasingly common among patients undergoing joint replacement and it creates a myriad of technical and medical challenges, and likely contributes to the financial burden of the surgery," said senior author David G. Lewallen, MD, an orthopaedic surgeon, also from Mayo Clinic.

In the related study, " Outcome of Total Knee Arthroplasty in Obese Patients," researchers in Singapore analyzed the outcomes of 301 TKA patients between December 2008 and April 2010 and grouped them according to BMI.

There was no difference in surgical time between obese and non-obese patients, although the obese patients had a longer hospital stay following TKR – 7.77 days versus 6.29 days for non-obese patients.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,102.30 -29.56 -0.17%
S&P 500 2,014.89 +15.91 0.80%
NASDAQ 4,833.1270 -5.5160 -0.11%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs